2023-05-012024-04-302024-04-30false11925190L & H VALENTINE LIMITED2025-01-2364209falseiso4217:GBPxbrli:pure119251902023-05-01119251902024-04-30119251902023-05-012024-04-30119251902022-05-01119251902023-04-30119251902022-05-012023-04-3011925190bus:SmallEntities2023-05-012024-04-3011925190bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3011925190bus:FullAccounts2023-05-012024-04-3011925190bus:PrivateLimitedCompanyLtd2023-05-012024-04-3011925190core:WithinOneYear2024-04-3011925190core:AfterOneYear2024-04-3011925190core:WithinOneYear2023-04-3011925190core:AfterOneYear2023-04-3011925190core:ShareCapital2024-04-3011925190core:SharePremium2024-04-3011925190core:RevaluationReserve2024-04-3011925190core:OtherReservesSubtotal2024-04-3011925190core:RetainedEarningsAccumulatedLosses2024-04-3011925190core:ShareCapital2023-04-3011925190core:SharePremium2023-04-3011925190core:RevaluationReserve2023-04-3011925190core:OtherReservesSubtotal2023-04-3011925190core:RetainedEarningsAccumulatedLosses2023-04-3011925190core:LandBuildings2024-04-3011925190core:PlantMachinery2024-04-3011925190core:Vehicles2024-04-3011925190core:FurnitureFittings2024-04-3011925190core:OfficeEquipment2024-04-3011925190core:NetGoodwill2024-04-3011925190core:IntangibleAssetsOtherThanGoodwill2024-04-3011925190core:ListedExchangeTraded2024-04-3011925190core:UnlistedNon-exchangeTraded2024-04-3011925190core:LandBuildings2023-04-3011925190core:PlantMachinery2023-04-3011925190core:Vehicles2023-04-3011925190core:FurnitureFittings2023-04-3011925190core:OfficeEquipment2023-04-3011925190core:NetGoodwill2023-04-3011925190core:IntangibleAssetsOtherThanGoodwill2023-04-3011925190core:ListedExchangeTraded2023-04-3011925190core:UnlistedNon-exchangeTraded2023-04-3011925190core:LandBuildings2023-05-012024-04-3011925190core:PlantMachinery2023-05-012024-04-3011925190core:Vehicles2023-05-012024-04-3011925190core:FurnitureFittings2023-05-012024-04-3011925190core:OfficeEquipment2023-05-012024-04-3011925190core:NetGoodwill2023-05-012024-04-3011925190core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011925190core:ListedExchangeTraded2023-05-012024-04-3011925190core:UnlistedNon-exchangeTraded2023-05-012024-04-3011925190core:MoreThanFiveYears2023-05-012024-04-3011925190core:Non-currentFinancialInstruments2024-04-3011925190core:Non-currentFinancialInstruments2023-04-3011925190dpl:CostSales2023-05-012024-04-3011925190dpl:DistributionCosts2023-05-012024-04-3011925190core:LandBuildings2023-05-012024-04-3011925190core:PlantMachinery2023-05-012024-04-3011925190core:Vehicles2023-05-012024-04-3011925190core:FurnitureFittings2023-05-012024-04-3011925190core:OfficeEquipment2023-05-012024-04-3011925190dpl:AdministrativeExpenses2023-05-012024-04-3011925190core:NetGoodwill2023-05-012024-04-3011925190core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011925190dpl:GroupUndertakings2023-05-012024-04-3011925190dpl:ParticipatingInterests2023-05-012024-04-3011925190dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3011925190core:ListedExchangeTraded2023-05-012024-04-3011925190dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3011925190core:UnlistedNon-exchangeTraded2023-05-012024-04-3011925190dpl:CostSales2022-05-012023-04-3011925190dpl:DistributionCosts2022-05-012023-04-3011925190core:LandBuildings2022-05-012023-04-3011925190core:PlantMachinery2022-05-012023-04-3011925190core:Vehicles2022-05-012023-04-3011925190core:FurnitureFittings2022-05-012023-04-3011925190core:OfficeEquipment2022-05-012023-04-3011925190dpl:AdministrativeExpenses2022-05-012023-04-3011925190core:NetGoodwill2022-05-012023-04-3011925190core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3011925190dpl:GroupUndertakings2022-05-012023-04-3011925190dpl:ParticipatingInterests2022-05-012023-04-3011925190dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-3011925190core:ListedExchangeTraded2022-05-012023-04-3011925190dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-3011925190core:UnlistedNon-exchangeTraded2022-05-012023-04-3011925190core:NetGoodwill2024-04-3011925190core:IntangibleAssetsOtherThanGoodwill2024-04-3011925190core:LandBuildings2024-04-3011925190core:PlantMachinery2024-04-3011925190core:Vehicles2024-04-3011925190core:FurnitureFittings2024-04-3011925190core:OfficeEquipment2024-04-3011925190core:AfterOneYear2024-04-3011925190core:WithinOneYear2024-04-3011925190core:ListedExchangeTraded2024-04-3011925190core:UnlistedNon-exchangeTraded2024-04-3011925190core:ShareCapital2024-04-3011925190core:SharePremium2024-04-3011925190core:RevaluationReserve2024-04-3011925190core:OtherReservesSubtotal2024-04-3011925190core:RetainedEarningsAccumulatedLosses2024-04-3011925190core:NetGoodwill2023-04-3011925190core:IntangibleAssetsOtherThanGoodwill2023-04-3011925190core:LandBuildings2023-04-3011925190core:PlantMachinery2023-04-3011925190core:Vehicles2023-04-3011925190core:FurnitureFittings2023-04-3011925190core:OfficeEquipment2023-04-3011925190core:AfterOneYear2023-04-3011925190core:WithinOneYear2023-04-3011925190core:ListedExchangeTraded2023-04-3011925190core:UnlistedNon-exchangeTraded2023-04-3011925190core:ShareCapital2023-04-3011925190core:SharePremium2023-04-3011925190core:RevaluationReserve2023-04-3011925190core:OtherReservesSubtotal2023-04-3011925190core:RetainedEarningsAccumulatedLosses2023-04-3011925190core:NetGoodwill2022-05-0111925190core:IntangibleAssetsOtherThanGoodwill2022-05-0111925190core:LandBuildings2022-05-0111925190core:PlantMachinery2022-05-0111925190core:Vehicles2022-05-0111925190core:FurnitureFittings2022-05-0111925190core:OfficeEquipment2022-05-0111925190core:AfterOneYear2022-05-0111925190core:WithinOneYear2022-05-0111925190core:ListedExchangeTraded2022-05-0111925190core:UnlistedNon-exchangeTraded2022-05-0111925190core:ShareCapital2022-05-0111925190core:SharePremium2022-05-0111925190core:RevaluationReserve2022-05-0111925190core:OtherReservesSubtotal2022-05-0111925190core:RetainedEarningsAccumulatedLosses2022-05-0111925190core:AfterOneYear2023-05-012024-04-3011925190core:WithinOneYear2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011925190core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3011925190core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3011925190core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3011925190core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3011925190core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3011925190bus:Director12023-05-012024-04-30

L & H VALENTINE LIMITED

Registered Number
11925190
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2024

L & H VALENTINE LIMITED
Company Information
for the year from 1 May 2023 to 30 April 2024

Director

VALENTINE, Luke Christopher, Dr

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

11925190 (England and Wales)
L & H VALENTINE LIMITED
Balance Sheet as at
30 April 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Investments3450450
450450
Current assets
Debtors4571,674539,769
Cash at bank and on hand4,098295
575,772540,064
Creditors amounts falling due within one year5(243,048)(205,740)
Net current assets (liabilities)332,724334,324
Total assets less current liabilities333,174334,774
Net assets333,174334,774
Capital and reserves
Called up share capital200200
Profit and loss account332,974334,574
Shareholders' funds333,174334,774
The financial statements were approved and authorised for issue by the Director on 23 January 2025, and are signed on its behalf by:
VALENTINE, Luke Christopher, Dr
Director
Registered Company No. 11925190
L & H VALENTINE LIMITED
Notes to the Financial Statements
for the year ended 30 April 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20242023
Average number of employees during the year00
3.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 May 23450450
At 30 April 24450450
Net book value
At 30 April 24450450
At 30 April 23450450

Notes

1Investments in group undertakings and participating interests
4.Debtors: amounts due within one year

2024

2023

££
Amounts owed by group undertakings571,674539,769
Total571,674539,769
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Amounts owed to related parties195,178178,700
Other creditors47,00026,500
Accrued liabilities and deferred income870540
Total243,048205,740
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Directors advances, credits and guarantees
Included in other creditors is an amount of £47,000(2023: £26,500) relates to the directors' loan account Dr. Luke Valentine.
7.Related party transactions
At the year-end, Amounts owed by/to group undertakings balance include £75,894 (2023: £80,644) due from THLV Commercial Properties Ltd and £250,225 (2023: £240,725) due from Valens Country Cottages Ltd and £160,605 (2023: £195,450) due from Crowborough Hill Pet Surgery Ltd and £84,950 (2023: £22,950) due from Staplehurst Pet Surgery Ltd and £126,100 (2023: £125,100) due to Five Oak Green Pet Ltd and £69,078 (2023: £53,600 Cr) due to LV Veterinary Services Ltd, where Dr. Luke Valentine is also director of those companies.